Ovarian Cancer Clinical Trial

ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study

Summary

The purpose of this study is to find out how well ovarian sentinel lymph nodes (SLNs) can be identified with indocyanine green (ICG) dye during risk-reducing ovarian surgery.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Women undergoing surgery with the Gynecology Service at MSK.

Women undergoing surgery for an adnexal mass without pre-operative suspicion of high stage disease, with or without a hysterectomy

°For this protocol, "suspected high stage disease" will be defined as any patient with radiologic or clinical evidence of ovarian cancer which has spread outside of the ovary. Thus, only patients with an adnexal mass, or bilateral adnexal masses, are eligible.

Women in whom MIS surgery is converted to a laparotomy will not be excluded as both surgical approaches, MIS and open, will be utilized.
Women >/= 18 years of age
Able to provide informed consent
Albumin levels within normal range

Exclusion Criteria:

Current non-GYN primary malignancy
Prior or current history of uterine, cervical, peritoneal, or vulvovaginal malignancy
Ongoing anticancer therapy
Prior bilateral oophorectomy
Known severe anaphylactic iodide allergy
Known history of cirrhosis or other chronic liver disease, or women with hepatic dysfunction.
Elevated transaminases (ALT, AST) and/or Alk Phos will be evaluated by the treating physician on a case by case basis.

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

55

Study ID:

NCT04051502

Recruitment Status:

Recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 7 Locations for this study

See Locations Near You

Memorial Sloan Kettering Basking Ridge (Consent only)
Basking Ridge New Jersey, 07920, United States More Info
Ginger Gardner, MD
Contact
212-639-2375
Memoral Sloan Kettering Monmouth (Consent only)
Middletown New Jersey, 07748, United States More Info
Ginger Gardner, MD
Contact
212-639-2375
Memorial Sloan Kettering Bergen (Consent only )
Montvale New Jersey, 07645, United States More Info
Ginger Gardner, MD
Contact
212-639-2375
Memorial Sloan Kettering Commack (Consent only)
Commack New York, 11725, United States More Info
Ginger Gardner, MD
Contact
212-639-2375
Memoral Sloan Kettering Westchester (Consent only)
Harrison New York, 10604, United States More Info
Ginger Gardner, MD
Contact
212-639-2375
Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States More Info
Ginger Gardner, MD
Contact
212-639-2375
Memorial Sloan Kettering Nassau (Consent only)
Uniondale New York, 11553, United States More Info
Ginger Gardner, MD
Contact
212-639-2375

How clear is this clinincal trial information?

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

55

Study ID:

NCT04051502

Recruitment Status:

Recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.